10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
19.15
0.00 (0.00%)
At close: Feb 11, 2026, 4:00 PM EST
19.17
+0.02 (0.10%)
After-hours: Feb 11, 2026, 7:30 PM EST
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.42 billion as of February 11, 2026. Its market cap has increased by 34.81% in one year.
Market Cap
2.42B
Enterprise Value
2.03B
1-Year Change
34.81%
Ranking
Category
Stock Price
$19.15
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $2.42B, a decrease of -51.05%. That is a compound annual growth rate of -10.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 2.42B | 17.41% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HealthEquity | 6.57B |
| Doximity | 4.80B |
| Waystar Holding | 4.54B |
| Hinge Health | 3.05B |
| Privia Health Group | 2.66B |
| HeartFlow | 2.30B |
| Omnicell | 1.70B |
| Certara | 1.10B |